i-Human Patients, Inc. (IHP) Company Profile

11:53 EDT 22nd March 2018 | BioPortfolio

i-Human Patients, Inc. (IHP) develops virtual medical training products and services, including its flagship i-Human Patients® platform, launched in November 2012, which educators at more than 20 percent of U.S. medical schools are subscribing to or developing content on in anticipation of future use. Cloud-based and interactive, i-Human improves training outcomes and clinical protocol compliance for students, instructors, and practicing clinicians using active learning strategies and content developed by leading medical educators at more than 40 schools.

News Articles [1134 Associated News Articles listed on BioPortfolio]

Cancer drug starts clinical trials in human brain-cancer patients

(University of Illinois at Urbana-Champaign) A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of human patients with anaplastic astrocytoma, a rare malignan...

Human API Teams Up with CMS to Launch FHIR-based API

Human API, the largest patient-centric health data network has announced a collaboration with the Center for Medicare and Medicaid Services (CMS) to make the new CMS Blue Button 2.0 API available thro...

New brain scanner allows patients to move freely for the first time

(Wellcome Trust) A new generation of brain scanner, that can be worn like a helmet allowing patients to move naturally whilst being scanned, has been developed by researchers at the Sir Peter Mansfiel...

UofL, Harvard, USF provide model for medical schools to teach signs of human trafficking

(University of Louisville) A new curriculum for third-year medical students teaches them to recognize patients who are being exploited in human trafficking.

Doc About Matchmaking for HIV Patients Explores 'Human Cost of Loneliness'

"Lovesick," a documentary that follows a matchmaking doctor and two of her patients with HIV, is scheduled to premiere at DOC NYC on Nov. 15

Prions Found in Skin of Creutzfeldt-Jakob Patients

Infectious protein aggregates from the skin of human patients can cause disease in mice.

Fully Functioning Artificial Human Heart Muscle Developed

Duke University researchers say they have created an artificial human heart muscle large enough to patch over damage seen in patients who have suffered a heart attack. The advance takes a major step t...

Human-sheep hybrid: Scientists just engineered a human-sheep hybrid for growing organs – Alphr

AlphrHuman-sheep hybrid: Scientists just engineered a human-sheep hybrid for growing organsAlphrBuilding on the human-pig hybrid engineered in the lab last year, scientists have now gone all Dolly on ...

Drugs and Medications [0 Results]


PubMed Articles [5317 Associated PubMed Articles listed on BioPortfolio]

Presence of human herpesvirus 8 (HHV-8) DNA sequences in patients with lymphoproliferative diseases and chronic blood disorders.

Human herpesvirus 8 (HHV-8) is the causative agent of Kaposi's sarcoma (KS), but it has also been associated with different hematologic malignancies, including plasmablastic lymphoma, Multicentric Cas...

The relationship between human dignity and medication adherence in patients with heart failure.

Medication adherence is a behavior that is influenced by several factors, and maintaining patients' dignity is an important issue that needs to be considered in the course of treatment. The present st...

Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in Brazilian patients with viral hepatitis B and C.

With this study, the authors hope to alert clinicians regarding the presence of human T-cell lymphotropic virus type 1 and 2 (HTLV-1/-2) infections in patients with viral hepatitis B and C in Brazil. ...

Omega-3 decreases IL-6 levels in HIV and human herpesvirus-8 coinfected patients in Uganda.

Kaposi sarcoma is a HIV-associated malignancy caused by human herpesvirus-8 (HHV-8) that occurs at highest incidence in sub-Saharan Africa. Kaposi sarcoma patients often present with inflammatory symp...

A Pilot Study of the Prevalence of Anal Human Papillomavirus and Dysplasia in a Cohort of Patients With IBD.

Defective cell-mediated immunity increases the risk of human papillomavirus-associated anal dysplasia and cancer. There is limited information on anal canal disease in patients with IBD.

Clinical Trials [2778 Associated Clinical Trials listed on BioPortfolio]

Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A

To compare the number of breakthrough bleeds under tailored prophylaxis with human cell line recombinant factor FVIII (Human-cl rhFVIII) with the historical bleeding rate from patients who...

Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology

A randomized, blinded, controlled trial to evaluate growth velocity and clinical outcomes in infants with single ventricle physiology fed an exclusive human milk diet prior to, and through...

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

RATIONALE: Vaccines made from certain human papillomaviruses may be able to help the body to kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of human papillomavi...

Discovering New Treatments for Asthma and COPD. A New Human Rhinvovirus for Human Challenge

A GMP rhinovirus was manufactured according to GMP and then characterised in human volunteers in the human viral challenge model.

Supplementation With Human Chorionic Gonadotropin (hCG) During Controlled Ovarian Stimulation With Recombinant Follicle-Stimulating Hormone (FSH) for In Vitro Fertilisation

The purpose of this trial is to study whether addition of different doses of human chorionic gonadotropins during controlled ovarian stimulation for patients undergoing IVF will improve th...

Companies [1812 Associated Companies listed on BioPortfolio]

i-Human Patients (IHP)

i-Human Patients, Inc. develops educational and competency assessment technology for the health care professional market, including its flagship i-Human Patients® platform, lau...

i-Human Patients, Inc.

i-Human Patients, Inc. develops virtual medical training products and services, including its flagship i-Human Patients® platform, launched in November 2012, which educators at...

i-Human Patients, Inc. (IHP)

i-Human Patients, Inc. (IHP) develops virtual medical training products and services, including its flagship i-Human Patients® platform, launched in November 2012, which educat...

KaloBios Pharmaceuticals, Inc.

KaloBios Pharmaceuticals, Inc., a U.S. based, private monoclonal company, uses its biologic capabilities and its proprietary platform technology to develop first-in-class human an...

Acceptys, Inc.

Acceptys is a private biotechnology company focused on the development of human antibody therapies in cancer and infectious diseases. The Company's key strength is its ability to directly leverage the...

More Information about "i-Human Patients, Inc. (IHP)" on BioPortfolio

We have published hundreds of i-Human Patients, Inc. (IHP) news stories on BioPortfolio along with dozens of i-Human Patients, Inc. (IHP) Clinical Trials and PubMed Articles about i-Human Patients, Inc. (IHP) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of i-Human Patients, Inc. (IHP) Companies in our database. You can also find out about relevant i-Human Patients, Inc. (IHP) Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record